Articles
Page 25 of 25
-
Citation: BMC Pharmacology and Toxicology 2012 13(Suppl 1):A56
-
Validation of a transparent decision model to rate drug interactions
Multiple databases provide ratings of drug-drug interactions. The ratings are often based on different criteria and lack background information on the decision making process. User acceptance of rating systems...
Citation: BMC Pharmacology and Toxicology 2012 13:7 -
Tox-Database.net: a curated resource for data describing chemical triggered in vitro cardiac ion channels inhibition
Drugs safety issues are now recognized as being factors generating the most reasons for drug withdrawals at various levels of development and at the post-approval stage. Among them cardiotoxicity remains the m...
Citation: BMC Pharmacology and Toxicology 2012 13:6 -
Microneedle pretreatment enhances the percutaneous permeation of hydrophilic compounds with high melting points
Two commercially available microneedle rollers with a needle length of 200 μm and 300 μm were selected to examine the influence of microneedle pretreatment on the percutaneous permeation of four non-steroidal ...
Citation: BMC Pharmacology and Toxicology 2012 13:5 -
Exploring the relationship between safety culture and reported dispensing errors in a large sample of Swedish community pharmacies
The potential for unsafe acts to result in harm to patients is constant risks to be managed in any health care delivery system including pharmacies. The number of reported errors is influenced by a various ele...
Citation: BMC Pharmacology and Toxicology 2012 13:4 -
The potential for selective pharmacological therapies through biased receptor signaling
The discovery that not all agonists uniformly activate cellular signaling pathways (biased signaling) has greatly changed the drug discovery process for agonists and the strategy for treatment of disease with ...
Citation: BMC Pharmacology and Toxicology 2012 13:3 -
An interview with Philip Biggin, Section Editor for Computational, in silico and modelling studies
Citation: BMC Pharmacology and Toxicology 2012 13:2 -
Only connect: the merger of BMC Pharmacology and BMC Clinical Pharmacology
This editorial celebrates the launch of BMC Pharmacology and Toxicology within the BMC series of journals published by BioMed Central. The scope of the journal is interdisciplinary encompassing toxicology, experi...
Citation: BMC Pharmacology and Toxicology 2012 13:1
Annual Journal Metrics
-
2022 Citation Impact
2.9 - 2-year Impact Factor
2.9 - 5-year Impact Factor
0.932 - SNIP (Source Normalized Impact per Paper)
0.603 - SJR (SCImago Journal Rank)2023 Speed
57 days submission to first editorial decision for all manuscripts (Median)
178 days submission to accept (Median)2023 Usage
790,731 downloads
400 Altmetric mentions
Peer-review Terminology
-
The following summary describes the peer review process for this journal:
Identity transparency: Single anonymized
Reviewer interacts with: Editor
Review information published: Review reports. Reviewer Identities reviewer opt in. Author/reviewer communication